Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis.
Tomas UherJan KrasenskyCharles MalpasNiels BergslandMichael G DwyerEva Kubala HavrdovaManuela VaneckovaDana HorakovaRobert ZivadinovTomas KalincikPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
The rate of BVL is relatively stable throughout the course of RRMS. The accelerated BVL is weakly associated with concurrent higher disease activity, and timely escalation to high-efficacy immunotherapy helps decrease the rate of BVL.